Immunoglobulin G from a Patient with Miller-Fisher Syndrome Rapidly and Reversibly Depresses Evoked Quantal Release at the Neuromuscular Junction of Mice
Overview
Authors
Affiliations
A neuromuscular blocking factor has been described in the serum of patients with Miller-Fisher syndrome (MFS). We here examined the effect of immunoglobulins (Ig) on neuromuscular transmission in mice recording quantal endplate currents by means of a perfused macro-patch-clamp electrode. Ig and IgM- and IgG-fractions from an anti-GQ1b-positive patient with typical MFS were highly purified. After application of MFS-IgG, quantal release decreased 1000-fold within 2 min. Returning to control solution the average release came back to the baseline level within 4 min. In contrast, control-IgG and MFS-IgM did not cause any blocking effect. The very fast and fully reversible presynaptic blockade of release caused by the highly purified IgG-fraction may be one factor producing muscle weakness in MFS.
The Neuroimmunology of Guillain-Barré Syndrome and the Potential Role of an Aging Immune System.
Hagen K, Ousman S Front Aging Neurosci. 2021; 12:613628.
PMID: 33584245 PMC: 7873882. DOI: 10.3389/fnagi.2020.613628.
Plomp J, Willison H J Physiol. 2009; 587(Pt 16):3979-99.
PMID: 19564393 PMC: 2756433. DOI: 10.1113/jphysiol.2009.171702.
Lo Y, Chan L, Pan A, Ratnagopal P J Neurol Neurosurg Psychiatry. 2004; 75(3):436-40.
PMID: 14966161 PMC: 1738963. DOI: 10.1136/jnnp.2003.023630.
OHanlon G, Bullens R, Plomp J, Willison H Neurochem Res. 2002; 27(7-8):697-709.
PMID: 12374204 DOI: 10.1023/a:1020284302718.
Campylobacter species and Guillain-Barré syndrome.
Nachamkin I, Allos B, Ho T Clin Microbiol Rev. 1998; 11(3):555-67.
PMID: 9665983 PMC: 88896. DOI: 10.1128/CMR.11.3.555.